Early Lapatinib-Induced Skin Rash Predicts Better Survival With
![](https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2018/12/scisource_2y033001_406484.jpg)
Early development of skin rash following lapatinib and trastuzumab therapy is associated with improved survival.
Lapatinib (Tyverb)
![](https://www.dovepress.com/getfile_article_fulltext.php?filename=article_fulltext%2Fs335000%2F335934/img/OTT_A_335934_O_F0002g.jpg)
HER-2 directed therapy in advanced breast cancer
![](https://d3i71xaburhd42.cloudfront.net/2638289607e2b2b16886448738cfa0353a4b3090/6-Table4-1.png)
PDF] Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO
![](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-019-0069-2/MediaObjects/41392_2019_69_Fig1_HTML.png)
Targeted therapeutic options and future perspectives for HER2
![](https://journals.sagepub.com/cms/10.4137/BCBCR.S6374/asset/images/large/10.4137_bcbcr.s6374-fig3.jpeg)
Efficacy and Tolerability of Lapatinib in the Management of Breast
![](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2011.237/MediaObjects/41416_2011_Article_BFbjc2011237_Fig1_HTML.jpg)
Effects of lapatinib monotherapy: results of a randomised phase II
![](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419385977-gr2.jpg)
Interdisciplinary management of EGFR-inhibitor-induced skin
![](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419385977-gr3.jpg)
Interdisciplinary management of EGFR-inhibitor-induced skin
![](https://i1.rgstatic.net/publication/366176679_Lapatinib_and_lapatinib_plus_trastuzumab_therapy_versus_trastuzumab_therapy_for_HER2_positive_breast_cancer_patients_an_updated_systematic_review_and_meta-analysis/links/63954a0c095a6a77741e99cf/largepreview.png)
PDF) Lapatinib and lapatinib plus trastuzumab therapy versus
![](https://ars.els-cdn.com/content/image/1-s2.0-S153300281630278X-gr3.jpg)
Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal
![](https://journals.sagepub.com/cms/10.4137/BCBCR.S6374/asset/images/large/10.4137_bcbcr.s6374-fig1.jpeg)
Efficacy and Tolerability of Lapatinib in the Management of Breast